Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
0.86
Open
0.86
Day Range0.84 – 0.87
0.84
0.87
52W Range0.73 – 1.51
0.73
1.51
16% of range
50-Day MA
0.86(-0.1%)
200-Day MA
0.94(-9.3%)
VOLUME & SIZE
Avg Volume
1.3M
FUNDAMENTALS
P/E (TTM)
-2.5x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
Beta
0.89
Market-like
TECHNICAL
RSI (14)
53
Bullish momentum
ONCY News
About
Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype -- turning 'cold' tumors 'hot' -- through innate and adaptive immune responses to treat a variety of cancers.